Sensus Healthcare PE ratio SRTS
Share price divided by earnings per share over the last twelve months, since 2022.
- Today, Oct 23, 2026
- n/m
- losses over the last year
- Last meaningful
- 34.7×
- Aug 2025
- 5-year median
- 13.4×
- 5-year range
- 3.2× to 127×
- Peer median
- 15.1×
Sensus Healthcare has no meaningful PE ratio today: it lost $0.94 a share over the last twelve months, and a PE needs earnings.
It was last meaningful in Aug 2025, at 34.7×.
On the days it had one over the last 5 years, its median was 13.4×, from 3.2× in Mar 2023 to 127× in Mar 2024.
PE ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2025 | 34.7× | 8.4× | 55.8× |
| 2024 | 12.6× | 12.5× | 127× |
| 2023 | 13.6× | 3.2× | 24.1× |
| 2022 | 4.6× | 3.7× | 44.8× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Sensus Healthcare's size, closest first, today.
| Company | PE ratio |
|---|---|
| SRTSSensus Healthcare | n/m |
| APTAlpha Pro Tech | 13.6× |
| NEPHNephros | 22.1× |
| KEQUKewaunee Scientific | 11.9× |
| PDEXPro DEX | 15.1× |
| UTMDUtah Medical Products | 22.6× |
| INFUInfuSystem | 34.0× |
| EMBCEmbecta | 4.6× |
| Peer median | 15.1× |
What the PE ratio tells you
Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.
Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.
More on Sensus Healthcare
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.